Aref Shariati

TL;DR: Since the prevalence of VRSA, VISA and hVISA has been increasing in recent years (especially in the Asian and American continents), rigorous monitoring of vancomycin treatment, it’s the therapeutic response and the definition of appropriate control guidelines depending on geographical regions is highly recommended and essential to prevent the further spread of van comycin-resistant S. aureus.

TL;DR: In this review, several strategies have been discussed for combating bacterial biofilms to improve healthcare, food safety, and industrial process.

TL;DR: The use of phage therapy for inhibition of P. aeruginosa biofilm in clinical and in vitro studies is discussed to identify different aspects of this treatment for broader use.

TL;DR: Resistance to new agents is low in staphylococci and these antibiotics can still be used for treatment of stAPHylococcal infections in the world, as shown in the present study.

TL;DR: This review focuses on an understanding of challenges of MDR, XDR, and PDR bacteria and phages mechanism for treating bacterial infections and the most recent studies on potential phages, cocktails of phage, and enzymes of lytic phages in fighting these resistant bacteria.